| Breakdown | TTM | Mar 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 17.38B | 16.71B | 14.58B | 12.44B | 10.39B | 10.71B |
| Gross Profit | 9.21B | 8.60B | 7.47B | 6.70B | 5.61B | 4.63B |
| EBITDA | 3.43B | 3.29B | 2.81B | 2.10B | 1.47B | 1.17B |
| Net Income | 966.64M | 917.23M | 646.96M | 432.65M | 128.87M | -129.34M |
Balance Sheet | ||||||
| Total Assets | 15.19B | 15.56B | 14.34B | 13.38B | 12.18B | 11.09B |
| Cash, Cash Equivalents and Short-Term Investments | 4.06B | 4.70B | 5.33B | 4.77B | 5.10B | 4.85B |
| Total Debt | 5.95B | 5.91B | 6.10B | 5.64B | 6.23B | 5.62B |
| Total Liabilities | 10.18B | 10.69B | 10.35B | 9.97B | 9.09B | 8.04B |
| Stockholders Equity | 5.01B | 4.87B | 3.99B | 3.40B | 3.09B | 3.05B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -102.51M | 264.62M | 497.52M | -133.36M | 490.39M |
| Operating Cash Flow | 0.00 | 2.51B | 2.54B | 2.55B | 1.59B | 1.06B |
| Investing Cash Flow | 0.00 | -2.73B | -2.44B | -2.18B | -1.93B | 112.13M |
| Financing Cash Flow | 0.00 | -305.46M | 347.74M | -698.28M | 528.54M | 924.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
81 Outperform | ¥8.89B | 16.36 | ― | 3.96% | 7.77% | 247.26% | |
66 Neutral | ¥7.18B | 10.89 | ― | 1.86% | 17.11% | 49.43% | |
63 Neutral | ¥1.43T | 42.60 | 5.92% | 1.93% | 7.64% | 22.13% | |
63 Neutral | ¥242.77B | 43.09 | ― | 2.18% | 10.50% | 27.82% | |
62 Neutral | ¥265.65B | 21.92 | 15.93% | 0.72% | 20.06% | 17.89% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
49 Neutral | ¥46.32B | 11.29 | ― | 3.94% | 0.74% | 41.25% |